» Articles » PMID: 37447206

Dietary Manipulation of Amino Acids for Cancer Therapy

Overview
Journal Nutrients
Date 2023 Jul 14
PMID 37447206
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer cells cannot proliferate and survive unless they obtain sufficient levels of the 20 proteinogenic amino acids (AAs). Unlike normal cells, cancer cells have genetic and metabolic alterations that may limit their capacity to obtain adequate levels of the 20 AAs in challenging metabolic environments. However, since normal diets provide all AAs at relatively constant levels and ratios, these potentially lethal genetic and metabolic defects are eventually harmless to cancer cells. If we temporarily replace the normal diet of cancer patients with artificial diets in which the levels of specific AAs are manipulated, cancer cells may be unable to proliferate and survive. This article reviews in vivo studies that have evaluated the antitumor activity of diets restricted in or supplemented with the 20 proteinogenic AAs, individually and in combination. It also reviews our recent studies that show that manipulating the levels of several AAs simultaneously can lead to marked survival improvements in mice with metastatic cancers.

Citing Articles

Cystine/cysteine metabolism regulates the progression and response to treatment of triple‑negative breast cancer (Review).

Xiao W, Xu C Oncol Lett. 2024; 28(5):521.

PMID: 39268159 PMC: 11391256. DOI: 10.3892/ol.2024.14654.


Nutritional intervention as adjuvant therapy for T-cell acute lymphoblastic leukemia.

Garcia M, Thandapani P Blood Adv. 2024; 8(20):5266-5267.

PMID: 39093954 PMC: 11492464. DOI: 10.1182/bloodadvances.2024013607.


A Diet Lacking Selenium, but Not Zinc, Copper or Manganese, Induces Anticancer Activity in Mice with Metastatic Cancers.

Diaz-Ortega P, Calderon-Montano J, Jimenez-Alonso J, Guillen-Mancina E, Jimenez-Gonzalez V, Burgos-Moron E Nutrients. 2024; 16(14).

PMID: 39064692 PMC: 11280272. DOI: 10.3390/nu16142249.


Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential.

Xiao Y, Gong Y, Qi Y, Shao Z, Jiang Y Signal Transduct Target Ther. 2024; 9(1):59.

PMID: 38462638 PMC: 10925609. DOI: 10.1038/s41392-024-01771-x.


Metabolic Heterogeneity, Plasticity, and Adaptation to "Glutamine Addiction" in Cancer Cells: The Role of Glutaminase and the GTωA [Glutamine Transaminase-ω-Amidase (Glutaminase II)] Pathway.

Cooper A, Dorai T, Pinto J, Denton T Biology (Basel). 2023; 12(8).

PMID: 37627015 PMC: 10452834. DOI: 10.3390/biology12081131.

References
1.
Olivares O, Mayers J, Gouirand V, Torrence M, Gicquel T, Borge L . Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Nat Commun. 2017; 8:16031. PMC: 5504351. DOI: 10.1038/ncomms16031. View

2.
Abou-Alfa G, Qin S, Ryoo B, Lu S, Yen C, Feng Y . Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma. Ann Oncol. 2018; 29(6):1402-1408. DOI: 10.1093/annonc/mdy101. View

3.
Elshorbagy A, Valdivia-Garcia M, Mattocks D, Plummer J, Smith A, Drevon C . Cysteine supplementation reverses methionine restriction effects on rat adiposity: significance of stearoyl-coenzyme A desaturase. J Lipid Res. 2010; 52(1):104-12. PMC: 2999932. DOI: 10.1194/jlr.M010215. View

4.
Missiaen R, Anderson N, Kim L, Nance B, Burrows M, Skuli N . GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment. Cell Metab. 2022; 34(8):1151-1167.e7. PMC: 9357184. DOI: 10.1016/j.cmet.2022.06.010. View

5.
Kerimoglu B, Lamb C, McPherson R, Ergen E, Stone E, Ooi A . Cyst(e)inase-Rapamycin Combination Induces Ferroptosis in Both In Vitro and In Vivo Models of Hereditary Leiomyomatosis and Renal Cell Cancer. Mol Cancer Ther. 2022; 21(3):419-426. PMC: 8898288. DOI: 10.1158/1535-7163.MCT-21-0661. View